Literature DB >> 10474287

Quality of life in low-income patients with metastatic prostate cancer: divergent and convergent validity of three instruments.

L K Sharp1, S J Knight, R Nadler, M Albers, E Moran, T Kuzel, R Sharifi, C Bennett.   

Abstract

Few studies have evaluated Quality Of Life (QOL) among low-income patients with cancer. Information is needed about the feasibility and psychometric characteristics of QOL instruments in these populations. The purpose of this study was to examine the convergent and discriminant relationships between scales of three QOL instruments: European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC), Functional Assessment of Cancer Therapy--General (FACT), and Quality of Life Index (QLI). Participants included 110 men with metastatic prostate cancer of whom 94% were low income and 62% were African-American. Interviewers administered the questionnaires. Cronbach alpha internal consistency reliabilities were 0.57 to 0.90 for the EORTC, 0.65 to 0.86 for the FACT, and 0.63 for the QLI. Convergent validity was supported for the EORTC and FACT scales measuring emotional, physical, and role/functional dimensions (r = 0.54 to 0.72), but not on scales measuring social function (r = 0.12). Divergent validity was supported between dissimilar scales (r = 0.14 to 0.38). Analysis with receiver operating characteristics curves provided empirical support for the EORTC and FACT as multidimensional measures. These findings suggest that, even in busy clinical settings with low literacy patients, interviewer-administered EORTC and FACT QOL instruments can provide valid and reliable information.

Entities:  

Mesh:

Year:  1999        PMID: 10474287     DOI: 10.1023/a:1008940015696

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  44 in total

1.  African-Americans and prostate cancer.

Authors:  P C Albertsen
Journal:  Cancer J Sci Am       Date:  1996 Jul-Aug

2.  A behavioral medicine approach to coping with cancer: a case report.

Authors:  R L Heinrich; C C Schag
Journal:  Cancer Nurs       Date:  1984-06       Impact factor: 2.592

3.  Immediate versus deferred treatment for advanced prostatic cancer: initial results of the Medical Research Council Trial. The Medical Research Council Prostate Cancer Working Party Investigators Group.

Authors: 
Journal:  Br J Urol       Date:  1997-02

4.  Cancer statistics, 1998.

Authors:  S H Landis; T Murray; S Bolden; P A Wingo
Journal:  CA Cancer J Clin       Date:  1998 Jan-Feb       Impact factor: 508.702

5.  Measuring quality of life in men with prostate cancer using the functional assessment of cancer therapy-prostate instrument.

Authors:  P Esper; F Mo; G Chodak; M Sinner; D Cella; K J Pienta
Journal:  Urology       Date:  1997-12       Impact factor: 2.649

Review 6.  Development of a comprehensive quality of life measurement tool: CARES.

Authors:  C A Schag; R L Heinrich
Journal:  Oncology (Williston Park)       Date:  1990-05       Impact factor: 2.990

7.  Measuring the quality of life of cancer patients: the Functional Living Index-Cancer: development and validation.

Authors:  H Schipper; J Clinch; A McMurray; M Levitt
Journal:  J Clin Oncol       Date:  1984-05       Impact factor: 44.544

Review 8.  Performance status assessment among oncology patients: a review.

Authors:  S T Orr; J Aisner
Journal:  Cancer Treat Rep       Date:  1986-12

9.  Randomized comparison of four tools measuring overall quality of life in patients with advanced cancer.

Authors:  J A Sloan; C L Loprinzi; S A Kuross; A W Miser; J R O'Fallon; M R Mahoney; I M Heid; M E Bretscher; N L Vaught
Journal:  J Clin Oncol       Date:  1998-11       Impact factor: 44.544

10.  Quality of life after palliative radiotherapy in patients with hormone-resistant prostate cancer: single institution experience.

Authors:  S D Fosså
Journal:  Br J Urol       Date:  1994-09
View more
  4 in total

Review 1.  Reliability across studies from the functional assessment of cancer therapy-general (FACT-G) and its subscales: a reliability generalization.

Authors:  David Victorson; Joshua Barocas; Juliette Song; David Cella
Journal:  Qual Life Res       Date:  2008-10-08       Impact factor: 4.147

2.  Measuring health-related quality of life in patients with advanced cancer: a systematic review of self-administered measurement instruments.

Authors:  Janneke van Roij; Heidi Fransen; Lonneke van de Poll-Franse; Myrte Zijlstra; Natasja Raijmakers
Journal:  Qual Life Res       Date:  2018-02-10       Impact factor: 4.147

3.  Reliability and Validity of Amharic Version of EORTC QLQ-C 30 Questionnaire among Gynecological Cancer Patients in Ethiopia.

Authors:  Birhanu Abera Ayana; Shiferaw Negash; Lukman Yusuf; Wendemagegnhu Tigeneh; Demewoz Haile
Journal:  PLoS One       Date:  2016-06-15       Impact factor: 3.240

4.  Reliability and validity of Amharic version of EORTC QLQ-C30 and QLQ-BR23 modules for assessing health-related quality of life among breast cancer patients in Ethiopia.

Authors:  Diriba Alemayehu Gadisa; Esayas Tadesse Gebremariam; Getnet Yimer Ali
Journal:  Health Qual Life Outcomes       Date:  2019-12-12       Impact factor: 3.186

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.